Journal Mobile Options
Table of Contents
Vol. 41, No. 1, 1986
Issue release date: 1986
Cytogenet Cell Genet 1986;41:38–41
Original Article

Localization of the human haptoglobin genes distal to the fragile site at 16q22 using in situ hybridization

Simmers R.N. · Stupans I. · Sutherland G.R.
Cytogenet Genome Res Unit, Department of Histopathology, Adelaide Children’s Hospital, North Adelaide


The distamycin A-sensitive fragile site fra(16)(q22) is a precisely localized chromosomal marker. When expressed at metaphase, it visibly separates the chromosome material on either side of the fragile site. Using a cDNA probe encoding both the α and β haptoglobin chains, the haptoglobin loci were found by in situ hybridization to be distal to fra(16)(q22).

 goto top of outline Author Contacts

Request reprints from: Ruth N. Simmers, Cytogenet Genome Res Unit, Department of Histopathology, Adelaide Children’s Hospital, North Adelaide, South Australia 5006 (Australia).

 goto top of outline Article Information

Received:: 25 March 1985
Published online: May 08, 2008
Number of Print Pages : 4

 goto top of outline Publication Details

Cytogenetic and Genome Research

Vol. 41, No. 1, Year 1986 (Cover Date: 1986)

Journal Editor: Schmid M. (Würzburg)
ISSN: 1424–8581 (Print), eISSN: 1424–859X (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.